Learn more →
Back to Expert Scholars
clinical / clinicalsarcoma oncology

Javier Martín-Broto

哈维尔·马丁-布罗托

MD, PhD

🏢Hospital Universitario Fundación Jiménez Díaz / Universidad Autónoma de Madrid(希门尼斯-迪亚斯基金会大学医院 / 马德里自治大学)🌐Spain

Head, Sarcoma and Connective Tissue Tumors Unit; Professor of Oncology肉瘤与结缔组织肿瘤单元主任;肿瘤学教授

38
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Javier Martín-Broto leads the sarcoma program at the Fundación Jiménez Díaz in Madrid and is one of Europe's most active sarcoma clinical trialists. His research program encompasses novel immunotherapeutic approaches including NY-ESO-1 cancer-testis antigen-directed therapies in synovial sarcoma, neoantigen-based vaccine strategies, and immune contexture in soft tissue sarcomas. He co-leads the Spanish Sarcoma Group (GEIS) clinical trial infrastructure and has run key Phase I/II trials of emerging sarcoma agents.

Share:

🧪Research Fields 研究领域

Soft Tissue Sarcoma软组织肉瘤
Leiomyosarcoma平滑肌肉瘤
Synovial Sarcoma滑膜肉瘤
Rhabdomyosarcoma横纹肌肉瘤
NY-ESO-1 ImmunotherapyNY-ESO-1免疫疗法

🎓Key Contributions 主要贡献

NY-ESO-1 Immunotherapy in Synovial Sarcoma

Contributed clinical and translational research characterizing NY-ESO-1 expression in synovial sarcoma and co-investigator on trials of TCR-engineered T cell therapy targeting NY-ESO-1, supporting the approval of afami-cel (Adaptimmune) in this subtype.

Spanish Sarcoma Group (GEIS) Clinical Trials

Led multiple GEIS-sponsored Phase II trials evaluating novel agents including trabectedin combinations, anti-angiogenic TKIs, and immunotherapy in specific sarcoma subtypes, establishing national and international treatment evidence.

Molecular Profiling and Personalized Sarcoma Therapy

Pioneered implementation of comprehensive molecular tumor profiling platforms for sarcoma in Spain, enabling histotype-specific and mutation-driven treatment selection and informing participation in basket trials.

Representative Works 代表性著作

[1]

Efficacy and Tolerance of Trabectedin in 132 Patients with Soft-Tissue Sarcoma: A Spanish Group for Research on Sarcomas (GEIS) Study

European Journal of Cancer (2016)

Real-world multi-center study demonstrating trabectedin efficacy and safety in Spanish sarcoma cohort.

[2]

Pazopanib in Pretreated Patients with Non-Adipocytic Soft Tissue Sarcoma: A GEIS Phase II Trial

Annals of Oncology (2020)

Phase II trial evaluating pazopanib activity in specific sarcoma subtypes in a pretreated Spanish cohort.

🏆Awards & Recognition 奖项与荣誉

🏆GEIS Award for Research Excellence 2018
🏆SEOM (Spanish Society of Medical Oncology) Sarcoma Prize 2020
🏆ESMO Faculty of Distinction 2022

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 哈维尔·马丁-布罗托 的研究动态

Follow Javier Martín-Broto's research updates

留下邮箱,当我们发布与 Javier Martín-Broto(Hospital Universitario Fundación Jiménez Díaz / Universidad Autónoma de Madrid)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment